342 related articles for article (PubMed ID: 16461183)
1. Cardiac consequences of aldosterone excess in human hypertension.
Rossi GP
Am J Hypertens; 2006 Jan; 19(1):10-2. PubMed ID: 16461183
[No Abstract] [Full Text] [Related]
2. Role of aldosterone in left ventricular hypertrophy in hypertension.
Matsumura K; Fujii K; Oniki H; Oka M; Iida M
Am J Hypertens; 2006 Jan; 19(1):13-8. PubMed ID: 16461184
[TBL] [Abstract][Full Text] [Related]
3. Left ventricular anatomy and function in primary aldosteronism and renovascular hypertension.
Pessina AC; Sacchetto A; Rossi GP
Adv Exp Med Biol; 1997; 432():63-9. PubMed ID: 9433512
[TBL] [Abstract][Full Text] [Related]
4. Hypertension, the adrenal and the kidney: lessons from pharmacologic interruption of the renin-angiotensin system.
Hollenberg NK; Williams GH
Adv Intern Med; 1980; 25():327-61. PubMed ID: 6153859
[No Abstract] [Full Text] [Related]
5. [The cardiac renin-angiotensin system and its role in ventricular hypertrophy associated with arterial hypertension].
Rubattu S; Volpe M; Raman V; Lindpaintner K
Cardiologia; 1997 Jan; 42(1):47-50. PubMed ID: 9118154
[No Abstract] [Full Text] [Related]
6. [Myocardial fibrosis--the theoretical bases, clinical aspects and therapeutic implications].
Perdigão C
Rev Port Cardiol; 1993; 12(7-8):675-85, 603. PubMed ID: 8352988
[TBL] [Abstract][Full Text] [Related]
7. Discordant effects of beta-blockade on central aortic systolic and brachial systolic blood pressure: considerations beyond the cuff.
Epstein BJ; Anderson S
Pharmacotherapy; 2007 Sep; 27(9):1322-33. PubMed ID: 17723086
[TBL] [Abstract][Full Text] [Related]
8. [Myocardial hypertrophy and fibrosis. New connections with the renin-angiotensin-aldosterone system].
Karlberg BE
Lakartidningen; 1993 Jan; 90(1-2):35-6. PubMed ID: 8421400
[No Abstract] [Full Text] [Related]
9. The renin-angiotensin-aldosterone system in primary and secondary hypertension.
del Greco F; Huang CM; Quintanilla A; Krumlovsky F; Roxe DM; Santhanam S
Ann Clin Lab Sci; 1981; 11(6):497-505. PubMed ID: 6119955
[TBL] [Abstract][Full Text] [Related]
10. [Pathophysiology of left ventricular hypertrophy in arterial hypertension].
Vallotton MB; Braconi-Quintaje S; Lang U
Praxis (Bern 1994); 1997 Feb; 86(7):234-7. PubMed ID: 9139339
[TBL] [Abstract][Full Text] [Related]
11. Blood pressure reduction is not the only determinant of outcome.
Sever PS; Poulter NR; Elliott WJ; Jonsson MC; Black HR; Sever PS; Poulter NR; Elliott WJ; Jonsson MC; Black HR
Circulation; 2006 Jun; 113(23):2754-72; discussion 2773-4. PubMed ID: 16769926
[No Abstract] [Full Text] [Related]
12. Left ventricular hypertrophy in hypertension: etiology, treatment, and controversies.
Phillips RA; Diamond JA; Gharavi A
Mt Sinai J Med; 1998 Mar; 65(2):97-103. PubMed ID: 9520512
[No Abstract] [Full Text] [Related]
13. Pharmacologic probes to identify patients with renovascular hypertension.
Sosa RE; Vaughan ED
Semin Urol; 1985 Nov; 3(4):317-24. PubMed ID: 2887024
[TBL] [Abstract][Full Text] [Related]
14. [Morphofunctional characteristics of myocardial hypertrophy in rabbits with vasorenal arterial hypertension during pharmacological blockade of angiotensin II].
Frolov VA; Drozdova GA; Mustiatsa VF; Balaev VV
Dokl Akad Nauk; 1999 May; 366(3):413-5. PubMed ID: 10420261
[No Abstract] [Full Text] [Related]
15. [Current data on the renin-angiotensin-aldosterone system. II. Involvement in infantile pathology].
Goţia S
Rev Med Chir Soc Med Nat Iasi; 1982; 86(4):573-8. PubMed ID: 7170508
[No Abstract] [Full Text] [Related]
16. Left-ventricular hypertrophy and coronary artery disease.
Pierdomenico SD
Am J Hypertens; 2007 Oct; 20(10):1036-7. PubMed ID: 17903684
[No Abstract] [Full Text] [Related]
17. [The renin-angiotensin system].
Hilgers KF
Urologe A; 2009 Aug; 48(8):925-33; quiz 934-5. PubMed ID: 19669119
[No Abstract] [Full Text] [Related]
18. Pathophysiology and clinical aspects of hypertensive hypertrophy.
Vogt M; Motz WH; Schwartzkopf B; Strauer BE
Eur Heart J; 1993 Jul; 14 Suppl D():2-7. PubMed ID: 8103741
[TBL] [Abstract][Full Text] [Related]
19. Calcium antagonism: aldosterone and vascular responses to catecholamines and angiotensin II in man.
Elliott HL
J Hypertens Suppl; 1993 Dec; 11(6):S13-6. PubMed ID: 8169376
[TBL] [Abstract][Full Text] [Related]
20. Renin-angiotensin-aldosterone system in hypertension. The clinical usefulness of measuring components of thisystem.
Ayers CR
Va Med Mon (1918); 1969 Jun; 96(6):312-4. PubMed ID: 4308355
[No Abstract] [Full Text] [Related]
[Next] [New Search]
